Skip to main content
TipRanks
Go Ultimate75% OFF

Indo Amines Limited (INDOAMIN) AI Stock Analysis

2 Followers
IN:INDOAMIN

Indo Amines Limited

(NSE:INDOAMIN)

Select Model
Rating:62Neutral
Price Target:INR 124.00â–²(5.98% Upside)
Action:reiterated
Date:10/07/26

The score is primarily held back by weak cash-flow quality (negative free cash flow in FY2025–FY2026) despite improved profitability and solid ROE. Technicals show a strong uptrend but overbought momentum (RSI ~74.6) adds near-term risk. Valuation is supportive with a moderate P/E (~12.9), though the low dividend yield offers limited income support.

Positive Factors
Revenue GrowthThe company is expanding sales across its amines and chemical-intermediate markets, indicating continued demand from downstream industrial customers. Sustained revenue growth can improve operating leverage, broaden customer reach, and provide a stronger base for future earnings generation.
Negative Factors
Weak Free Cash FlowRepeated negative free cash flow means reported profits have not consistently converted into surplus cash after investment needs. This can constrain internally funded expansion and increase reliance on financing or working-capital improvement to support the business.

Indo Amines Limited (INDOAMIN) vs. iShares MSCI India ETF (INDA)

-40%-30%-20%-10%0%10%20%30%IN:INDOAMIN-9.57%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 10.39B
Dividend Yield
0.43%
Average Volume (3M)
24.92K
Price to Earnings (P/E)
10.4
Beta (1Y)
1.45
Revenue Growth
13.23%
EPS Growth
22.22%
Country
India
Employees
619
Sector
General
Sector Strength
55
Industry
Chemicals

Indo Amines Limited Business Overview & Revenue Model

Company Description

Indo Amines Limited operates as a global manufacturer and supplier, focusing on the development and production of a comprehensive range of chemicals, including fine, specialty, performance, and perfumery chemicals, alongside active pharmaceutical ing...

How the Company Makes Money

Indo Amines Limited makes money mainly by manufacturing and selling amines and amine-based specialty/intermediate chemicals to other businesses. Revenue is generated through (1) sale of manufactured chemical products: the company produces amines and...

Indo Amines Limited Financial Statement Overview

Summary

Profitability and returns improved in FY2026 (net margin ~6.8%, operating margin ~8.7%, ROE ~20.2%) and leverage is moderate with a better debt-to-equity trend (~0.79). However, cash conversion is a major drag: free cash flow was negative in FY2025 and FY2026 (about -0.22B each year) and operating cash flow is uneven, increasing funding/working-capital risk.

Income Statement

74Positive

Balance Sheet

66Positive

Cash Flow

42Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue12.47B11.60B10.79B9.40B9.41B7.79B
Gross Profit3.37B3.04B2.75B2.20B2.30B1.91B
EBITDA1.57B1.23B1.16B936.55M913.41M604.51M
Net Income812.40M793.26M558.95M428.13M408.75M230.47M
Balance Sheet
Total Assets08.97B7.79B6.33B5.97B5.54B
Cash, Cash Equivalents and Short-Term Investments237.05M237.05M167.79M55.89M60.73M61.66M
Total Debt03.11B2.84B2.17B2.32B2.07B
Total Liabilities-3.94B5.04B4.61B3.70B3.71B3.67B
Stockholders Equity3.94B3.92B3.17B2.63B2.25B1.87B
Cash Flow
Free Cash Flow-81.70M-220.64M-216.82M391.02M-109.75M-242.71M
Operating Cash Flow363.28M563.71M697.01M696.71M203.63M154.59M
Investing Cash Flow-375.71M-718.75M-904.58M-265.64M-298.27M-388.40M
Financing Cash Flow66.32M225.81M153.96M-408.70M40.26M319.15M

Indo Amines Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price117.00

Price Trends

50DMA132.42Negative
100DMA130.12Negative
200DMA121.84Negative

Market Momentum

MACD-5.08Positive
RSI37.46Neutral
STOCH14.07Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDOAMIN, the sentiment is Negative. The current price of 117.00 is below the 20-day moving average (MA) of 126.15, below the 50-day MA of 132.42, and below the 200-day MA of 121.84, indicating a bearish trend. The MACD of -5.08 indicates Positive momentum. The RSI at 37.46 is Neutral, neither overbought nor oversold. The STOCH value of 14.07 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INDOAMIN.

Indo Amines Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:INDOAMIN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:INDIAGLYCOIN:INDIAGLYCO64NeutralINR 20.86B6.29―0.83%12.01%23.71%
IN:VALIANTORGIN:VALIANTORG63NeutralINR 10.18B15.44――21.32%175.87%
IN:AMNPLSTIN:AMNPLST62NeutralINR 9.88B20.34―0.28%-5.09%12.63%
IN:INDOAMININ:INDOAMIN62NeutralINR 8.49B10.40―0.43%13.23%22.22%
IN:PRIMOIN:PRIMO59NeutralINR 5.13B32.75――-2.70%-15.41%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:DMCCIN:DMCC53NeutralINR 6.18B16.33―1.00%72.14%34.49%

* General Sector Average

Performance Comparison

-25%0%25%50%IN:INDOAMININ:AMNPLSTIN:DMCCIN:INDIAGLYCOIN:PRIMOIN:VALIANTORGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:INDOAMIN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:INDOAMINIndo Amines Limited117.00-14.17-10.80%
IN:AMNPLSTAmines & Plasticizers Ltd.179.50-20.00-10.03%
IN:DMCCDMCC Speciality Chemicals Limited247.70-31.84-11.39%
IN:INDIAGLYCOIndia Glycols Limited311.1585.6337.97%
IN:PRIMOPrimo Chemicals Limited21.18-1.43-6.32%
IN:VALIANTORGValiant Organics Limited363.3077.4527.09%

Indo Amines Limited Corporate Events

Indo Amines halts Mahad plant after fatal gas leak incident

Aug 17, 2026

Indo Amines Limited has reported a gas leakage incident at its Mahad manufacturing facility in Raigad, Maharashtra, on 15 August 2026, which resulted in the death of one company worker and a person from a neighbouring industrial unit, while others in...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 06, 2026